Esther A. Croes

4.2k total citations
54 papers, 990 citations indexed

About

Esther A. Croes is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Esther A. Croes has authored 54 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Epidemiology and 10 papers in Hepatology. Recurrent topics in Esther A. Croes's work include Prion Diseases and Protein Misfolding (12 papers), Hepatitis C virus research (9 papers) and Smoking Behavior and Cessation (7 papers). Esther A. Croes is often cited by papers focused on Prion Diseases and Protein Misfolding (12 papers), Hepatitis C virus research (9 papers) and Smoking Behavior and Cessation (7 papers). Esther A. Croes collaborates with scholars based in Netherlands, Belgium and France. Esther A. Croes's co-authors include Cornelia M. van Duijn, Christine Van Broeckhoven, Marc C. Willemsen, Fakhredin A. Sayed‐Tabatabaei, Sandra López‐León, Stephan Claes, Geoffrey T. Fong, Annick Alpérovitch, Petra Hopman and Anne C K Quah and has published in prestigious journals such as The Lancet, Neurology and Stroke.

In The Last Decade

Esther A. Croes

49 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther A. Croes Netherlands 16 386 195 187 181 149 54 990
Yu-Chen Kao Taiwan 19 144 0.4× 232 1.2× 162 0.9× 147 0.8× 108 0.7× 42 1.0k
Basharat Hussain Pakistan 8 180 0.5× 134 0.7× 74 0.4× 253 1.4× 58 0.4× 49 868
S. Malhotra India 17 141 0.4× 95 0.5× 136 0.7× 210 1.2× 59 0.4× 42 1.0k
Mohammed Ayalew Ethiopia 15 192 0.5× 52 0.3× 174 0.9× 17 0.1× 115 0.8× 32 946
Alessandro Gialluisi Italy 18 220 0.6× 154 0.8× 48 0.3× 30 0.2× 76 0.5× 63 950
Glenna Brewster United States 17 303 0.8× 120 0.6× 164 0.9× 15 0.1× 87 0.6× 47 1.2k
Hiroshi Yamashita Japan 19 186 0.5× 126 0.6× 222 1.2× 14 0.1× 126 0.8× 60 1.1k
Angela LaRosa United States 14 133 0.3× 155 0.8× 189 1.0× 23 0.1× 53 0.4× 30 789
Jinfeng Miao China 14 114 0.3× 61 0.3× 278 1.5× 114 0.6× 152 1.0× 45 851
Nikki Davis United Kingdom 11 138 0.4× 37 0.2× 35 0.2× 51 0.3× 72 0.5× 21 518

Countries citing papers authored by Esther A. Croes

Since Specialization
Citations

This map shows the geographic impact of Esther A. Croes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther A. Croes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther A. Croes more than expected).

Fields of papers citing papers by Esther A. Croes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther A. Croes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther A. Croes. The network helps show where Esther A. Croes may publish in the future.

Co-authorship network of co-authors of Esther A. Croes

This figure shows the co-authorship network connecting the top 25 collaborators of Esther A. Croes. A scholar is included among the top collaborators of Esther A. Croes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther A. Croes. Esther A. Croes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Croes, Esther A., et al.. (2025). Rising incidence of recreational ketamine use: Clinical cases and management in emergency settings. Toxicology Reports. 14. 101940–101940. 1 indexed citations
2.
Kramer, Iris, et al.. (2024). Risk of death due to COVID-19 among current and former smokers in the Netherlands: a population-based quasi-cohort study. International Journal of Epidemiology. 53(1). 1 indexed citations
3.
Kramer, Iris, et al.. (2024). New insights into the paradox between smoking and the risk of SARS-CoV-2 infection (COVID-19): Insufficient evidence for a causal association. Scandinavian Journal of Public Health. 53(5). 552–559. 1 indexed citations
4.
Croes, Esther A., et al.. (2022). Proactive Referral to Behavioral Smoking Cessation Programs by Healthcare Staff: A Systematic Review. Nicotine & Tobacco Research. 25(5). 849–858. 5 indexed citations
5.
Hopman, Petra, Bethany Hipple Walters, Esther A. Croes, et al.. (2020). The double-edged relationship between COVID-19 stress andsmoking: Implications for smoking cessation. Tobacco Induced Diseases. 18(July). 63–63. 138 indexed citations
6.
Koopsen, Jelle, Jim van Steenbergen, Jan Hendrik Richardus, et al.. (2019). Chronic hepatitis B and C infections in the Netherlands: estimated prevalence in risk groups and the general population. Epidemiology and Infection. 147. e147–e147. 30 indexed citations
7.
Verhagen, M.A.M.T., et al.. (2019). Introducing hepatitis C virus healthcare pathways in addiction care in the Netherlands with a Breakthrough project: a mixed method study. Harm Reduction Journal. 16(1). 45–45. 5 indexed citations
8.
Arends, Joop E., et al.. (2018). Strategies for achieving viral hepatitis C micro-elimination in the Netherlands. PubMed. 3(1). 12–12. 22 indexed citations
9.
Bergh, Christina, Peter Harteloh, & Esther A. Croes. (2017). [Leading cause of death in young Dutch people: the cigarette].. PubMed. 161. D1991–D1991. 2 indexed citations
10.
Chavannes, Niels H., et al.. (2017). PubMed. 161. D1394–D1394. 9 indexed citations
11.
Croes, Esther A., et al.. (2015). Verbetering van de opsporing van hepatitis C in de verslavingszorg. TSG - Tijdschrift voor gezondheidswetenschappen. 93(4). 129–132. 2 indexed citations
12.
Croes, Esther A., et al.. (2013). Aandacht gevraagd voor hepatitis C in de verslavingszorg. 9(2). 34–42. 2 indexed citations
13.
Laar, Margriet van, et al.. (2010). The Netherlands drug situation 2009. Data Archiving and Networked Services (DANS). 4 indexed citations
14.
Laar, Margriet van, et al.. (2009). Drug situation 2008 - The Netherlands : report to the EMCDDA by the Reitox National Focal Point. 9 indexed citations
15.
16.
Laar, Margriet van, et al.. (2007). Drug situation 2006 - the Netherlands. 1 indexed citations
17.
Croes, Esther A., Behrooz Z. Alizadeh, Aida M. Bertoli‐Avella, et al.. (2004). Polymorphisms in the prion protein gene and in the doppel gene increase susceptibility for Creutzfeldt–Jakob disease. European Journal of Human Genetics. 12(5). 389–394. 36 indexed citations
18.
Croes, Esther A.. (2002). Creutzfeldt-Jakob disease 38 years after diagnostic use of human growth hormone. Journal of Neurology Neurosurgery & Psychiatry. 72(6). 792–793. 15 indexed citations
19.
Beck, Jon, Simon Mead, Tracy Campbell, et al.. (2001). Two-octapeptide repeat deletion of prion protein associated with rapidly progressive dementia. Neurology. 57(2). 354–356. 49 indexed citations
20.
Croes, Esther A., T.M. van Gulik, A. Bosma, L T de Wit, & D. J. Gouma. (1998). [Treatment of 8 patients with an acute hemorrhage in a hepatocellular adenoma at the Academic Medical Center, Amsterdam].. PubMed. 142(45). 2463–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu-Chen Kao Breakdown of academic impact, for papers by Basharat Hussain Breakdown of academic impact, for papers by S. Malhotra Breakdown of academic impact, for papers by Mohammed Ayalew Breakdown of academic impact, for papers by Alessandro Gialluisi Breakdown of academic impact, for papers by Glenna Brewster Breakdown of academic impact, for papers by Hiroshi Yamashita Breakdown of academic impact, for papers by Angela LaRosa Breakdown of academic impact, for papers by Jinfeng Miao Breakdown of academic impact, for papers by Nikki Davis
Rankless by CCL
2026